Rising Smoking Prevalence & Aging Demographics Drive Global COPD Treatment Demand
The Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Valued at USD 31.14 billion in 2026, the global market is projected to expand at a robust compound annual growth rate (CAGR) of 6.25% over the forecast period, reaching an estimated USD 50.57 billion by 2034. The global respiratory therapeutics landscape is experiencing a paradigm shift. For decades, the chronic obstructive...
0 Commentarios 0 Acciones 49 Views 0 Vista previa